DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION

Comerica Incorporated

DB:CA3 Stock Report

Market Cap: €9.6b

  • Company Overview
  • Valuation
  • Future Growth
  • Past Performance
  • Financial Health
  • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

Comerica Valuation

Is CA3 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Future Cash Flow Value

  • Significantly Below Future Cash Flow Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CA3 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Ultimate guide to DCF valuation for stock investing

Learn how to determine fair value like the best investors in the world.

Below Future Cash Flow Value: CA3 (€77) is trading below our estimate of future cash flow value (€85.74)

Significantly Below Future Cash Flow Value: CA3 is trading below future cash flow value, but not by a significant amount.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for CA3?

Key metric: As CA3 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for CA3. This is calculated by dividing CA3's market cap by their current earnings.
What is CA3's PE Ratio?
PE Ratio16.4x
EarningsUS$691.00m
Market CapUS$11.35b
CA3 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenuen/a
Enterprise Value/EBITDAn/a
PEG Ratio-13.1x

Price to Earnings Ratio vs Peers

How does CA3's PE Ratio compare to its peers?

  • Price to Earnings
  • Price to Sales
  • Price to Book
The above table shows the PE ratio for CA3 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average10.8x
CBK Commerzbank
16.1x12.66%€45.5b
PCZ ProCredit Holding
6.8x23.25%€518.9m
MBK Merkur PrivatBank KgaA
8.3x9.10%€96.5m
TPEIR Piraeus Bank
12x10.79%€12.9b
CA3 Comerica
16.4x-1.25%€11.3b

Price-To-Earnings vs Peers: CA3 is expensive based on its Price-To-Earnings Ratio (16.4x) compared to the peer average (10.8x).


Historical Price to Earnings Ratio

Historical Price to Earnings Ratio compares a stock's price to its earnings over time. Higher ratios indicate that investors are willing to pay more for the stock.

  • Price to Earnings
  • Price to Sales
  • Price to Book

Fetching historical data


Price to Earnings Ratio vs Industry

How does CA3's PE Ratio compare vs other companies in the European Banks Industry?

  • Price to Earnings
  • Price to Sales
  • Price to Book
3 CompaniesPrice / EarningsEstimated GrowthMarket Cap
CA3 16.4xIndustry Avg. 12.2xNo. of Companies36PE0612182430+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: CA3 is expensive based on its Price-To-Earnings Ratio (16.4x) compared to the European Banks industry average (11.5x).


Price to Earnings Ratio vs Fair Ratio

What is CA3's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CA3 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio16.4x
Fair PE Ratio11.4x

Price-To-Earnings vs Fair Ratio: CA3 is expensive based on its Price-To-Earnings Ratio (16.4x) compared to the estimated Fair Price-To-Earnings Ratio (11.4x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst CA3 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Currentn/a
€73.70
0%
13.04%€89.92€57.68n/a8
Sep ’27n/a
€73.70
0%
13.04%€89.92€57.68n/a8
Aug ’27n/a
€73.70
0%
13.04%€89.92€57.68n/a8
Jul ’27n/a
€73.70
0%
13.04%€89.92€57.68n/a8
Jun ’27n/a
€73.70
0%
13.04%€89.92€57.68n/a8
May ’27n/a
€73.70
0%
13.04%€89.92€57.68n/a8
Apr ’27n/a
€73.70
0%
13.04%€89.92€57.68n/a8
Mar ’27n/a
€73.70
0%
13.04%€89.92€57.68n/a8
Feb ’27€77.00
€74.78
-2.88%
14.56%€96.12€55.65n/a16
Jan ’27€74.50
€70.38
-5.53%
11.05%€84.29€56.19n/a18
Dec ’26€68.50
€70.06
+2.28%
10.20%€83.56€56.85n/a18
Nov ’26€66.50
€69.88
+5.09%
10.87%€84.15€57.26n/a18
Oct ’26€58.00
€58.80
+1.38%
7.52%€64.77€47.72n/a22
Sep ’26€60.00
€57.31
-4.49%
7.79%€64.49€48.15n/a20
Aug ’26€58.50
€57.36
-1.94%
9.56%€65.69€43.79n/a20
Jul ’26€50.50
€51.27
+1.53%
9.51%€63.62€39.87n/a20
Jun ’26€49.80
€51.85
+4.12%
10.98%€66.02€41.37n/a20
May ’26€47.20
€52.08
+10.34%
10.27%€65.91€43.94n/a19
Apr ’26€54.00
€61.73
+14.32%
10.09%€74.15€50.05n/a20
Mar ’26€61.00
€65.71
+7.72%
8.81%€76.07€56.10n/a20
Feb ’26€64.50
€66.18
+2.60%
8.30%€77.18€56.92€77.0020
Jan ’26€59.00
€69.01
+16.96%
11.00%€82.02€55.00€74.5020
Dec ’25€68.50
€65.53
-4.33%
10.25%€80.99€54.31€68.5021
Nov ’25€58.50
€61.09
+4.43%
10.27%€73.98€47.16€66.5022
Oct ’25€53.50
€52.68
-1.54%
11.66%€67.36€38.62€58.0022
Sep ’25€51.00
€49.72
-2.52%
9.04%€58.28€38.55€60.0023
AN
AnalystPriceTarget
AnalystPriceTarget
Member since 2015
€75.44
Fair Value
2.1% overvalued intrinsic discount
8
Number of Analysts

Analyst Forecast: Target price is lower than the current share price.


Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/02/03 21:22
End of Day Share Price 2026/01/30 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Comerica Incorporated is covered by 32 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kevin HealArgus Research Company
David GeorgeBaird
Kevin St. PierreBernstein

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide